Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-3-18
pubmed:abstractText
NKX3.1 is a homeobox gene that codes for a haploinsufficient prostate cancer tumor suppressor. NKX3.1 protein levels are down-regulated in the majority of primary prostate cancer tissues. NKX3.1 expression in PC-3 cells increased insulin-like growth factor binding protein-3 (IGFBP-3) mRNA expression 10-fold as determined by expression microarray analysis. In both stably and transiently transfected PC-3 cells and in LNCaP cells, NKX3.1 expression increased IGFBP-3 mRNA and protein expression. In prostates of Nkx3.1 gene-targeted mice Igfbp-3 mRNA levels correlated with Nkx3.1 copy number. NKX3.1 expression in PC-3 cells attenuated the ability of insulin-like growth factor-I (IGF-I) to induce phosphorylation of type I IGF receptor (IGF-IR), insulin receptor substrate 1, phosphatidylinositol 3-kinase, and AKT. The effect of NKX3.1 on IGF-I signaling was not seen when cells were exposed to long-R3-IGF-I, an IGF-I variant peptide that does not bind to IGFBP-3. Additionally, small interfering RNA-induced knockdown of IGFBP-3 expression partially reversed the attenuation of IGF-IR signaling by NKX3.1 and abrogated NKX3.1 suppression of PC-3 cell proliferation. Thus, there is a close relationship in vitro and in vivo between NKX3.1 and IGFBP-3. The growth-suppressive effects of NKX3.1 in prostate cells are mediated, in part, by activation of IGFBP-3 expression.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1538-7445
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2615-22
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19258508-Animals, pubmed-meshheading:19258508-Cell Growth Processes, pubmed-meshheading:19258508-Cell Line, Tumor, pubmed-meshheading:19258508-Gene Expression, pubmed-meshheading:19258508-Glioblastoma, pubmed-meshheading:19258508-Homeodomain Proteins, pubmed-meshheading:19258508-Humans, pubmed-meshheading:19258508-Insulin-Like Growth Factor Binding Protein 3, pubmed-meshheading:19258508-Insulin-Like Growth Factor Binding Proteins, pubmed-meshheading:19258508-Insulin-Like Growth Factor I, pubmed-meshheading:19258508-Male, pubmed-meshheading:19258508-Mice, pubmed-meshheading:19258508-Prostatic Neoplasms, pubmed-meshheading:19258508-RNA, Messenger, pubmed-meshheading:19258508-Signal Transduction, pubmed-meshheading:19258508-Transcription Factors, pubmed-meshheading:19258508-Transfection, pubmed-meshheading:19258508-Transplantation, Heterologous
pubmed:year
2009
pubmed:articleTitle
NKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferation.
pubmed:affiliation
Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural